Companies / Santa Cruz Biotechnology / Dok-1 (A-3) PE
Santa Cruz Biotechnology

Dok-1 (A-3) PE | Santa Cruz Biotechnology

mouse monoclonal IgG1; Dok-1 Antibody (A-3) is an IgG1 κ mouse monoclonal Dok-1 antibody (also designated DOK1 antibody) that detects the Dok-1 protein of mouse, rat and human origin by WB, IP, IF and IHC(P). Dok-1 Antibody (A-3) is available as both the non-conjugated anti-Dok-1 antibody form, as well as multiple conjugated forms of anti-Dok-1 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Dok-1 associates with the Ras GTPase-activating protein (Ras GAP) upon tyrosine phosphorylation. Evidence suggests that Dok-1 (also designated p62dok) is a substrate of the constitutive tyrosine kinase activity of p210 Bcr-Abl, a fusion protein caused by the t(9;22) translocation and associated with chronic myelogenous leukemia. Dok-1, as well as the tyrosine kinase substrates IRS-1 and Cas, are members of a class of "docking" proteins which contain multiple tyrosine residues and putative SH2 binding sites. Dok-1 is suspected to be the substrate phosphorylated in response to stimulation by a number of growth factors, including PDGF, VEGF, insulin and IGF. Dok-2 (also designated p56dok) has also been identified as a potential mediator of the effects of p210 Bcr-Abl.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.